Mild Cognitive Impairment Clinical Trial
— FeuersteinOfficial title:
An Evaluation of the Feuerstein Instrumental Enrichment Program for the Cognitive Enhancement of Older People With Mild Cognitive Impairment (MCI) Living in the Community
Verified date | September 2019 |
Source | Rambam Health Care Campus |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: The Feuerstein Instrumental Enrichment Program was designed to prevent mental
deterioration and preserve cognitive abilities among people aged 60 and above. The program is
an applied practicable program based on the theories of Structural Cognitive Modifiability as
well as on a Mediated Learning Experience. The program takes into consideration the unique
characteristics and requirements of the older population. The program is composed of a
variety of cognitive tasks that offer systematic activities intended to stimulate mental and
cognitive development.
Objective: To examine the influence of the Feuerstein Program on the cognitive function and
well-being of participants suffering from Mild Cognitive Impairment (MCI).
Hypothesis: The Feuerstein Program will improve cognitive abilities and functional well-being
of the participants.
Methods: Residents of retirement homes will be offered to participate in the research.
Participants will undergo cognitive and functional assessments that will be carried out on
four specific dates. The participants of the Intervention Group will participate in the
Feuerstein program using a method of mediated learning while the Control Group will
participate in a program of the Adler Institute involving activities aimed at social and
emotional development without specific cognitive skill training.
Status | Completed |
Enrollment | 26 |
Est. completion date | May 31, 2016 |
Est. primary completion date | May 31, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: 1. Aged 60 and above. 2. Hebrew/English speakers. 3. Expressing willingness to participate in the research and deliberately signing a consent form. 4. A diagnosis of MCI exists according to accepted clinical criteria - the examinee's score in the MoCA Test is within the range of 18-26 (inclusive). Exclusion Criteria: 1. A medical or functional condition that will not allow the patient to participate in the intervention program within the research period. 2. Diagnosed patients suffering from depression, bipolar disorder or schizophrenia. 3. Patients who suffer from a diagnosed cognitive impairment other than MCI (delirium dementia or mental retardation). 4. Visual impairment that hasn't been amended by glasses. 5. Hearing impairment that hasn't been amended by a hearing aid. 6. Examinees whose MoCA Test's score is 17 and below or 27 and above. 7. Examinees who will receive the maximal score in one or more sections of the Lawton Test. 8. Examinees who will respond positively to a filter question regarding the topic of depression. |
Country | Name | City | State |
---|---|---|---|
Israel | Beit Yona | Beersheba | |
Israel | Beit Tovei Hair | Jerusalem | |
Israel | Ramat Tamir Retirement Home | Jerusalem | |
Israel | Bayit Balev Beit Ildan | Qiryat Mo?qin | |
Israel | Bayit Balev Tel Aviv | Tel Aviv |
Lead Sponsor | Collaborator |
---|---|
Rambam Health Care Campus | Adolf und Mary Mil-Stiftung, Helen Bader Foundation, Montreal Jewish Community Fund, Rochlin Family Foundation |
Israel,
Carmel S. The will to live: gender differences among elderly persons. Soc Sci Med. 2001 Mar;52(6):949-58. — View Citation
Dwolatzky T, Whitehead V, Doniger GM, Simon ES, Schweiger A, Jaffe D, Chertkow H. Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatr. 2003 Nov 2;3:4. — View Citation
Lachs MS, Feinstein AR, Cooney LM Jr, Drickamer MA, Marottoli RA, Pannill FC, Tinetti ME. A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med. 1990 May 1;112(9):699-706. — View Citation
Lifshitz M, Dwolatzky T, Press Y. Validation of the Hebrew version of the MoCA test as a screening instrument for the early detection of mild cognitive impairment in elderly individuals. J Geriatr Psychiatry Neurol. 2012 Sep;25(3):155-61. doi: 10.1177/0891988712457047. — View Citation
Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167-76. doi: 10.1159/000376585. Epub 2015 Mar 28. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline cognitive function | Based on Neurotrax computerized neuropsychological assessment battery | Through study completion, an average of 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A | |
Completed |
NCT04817176 -
MI-CBT Adherence Program for Lifestyle Interventions in Older Adults
|
Early Phase 1 |